MSH3 and neoplasm: Mutations in one or more genes encoding MMR proteins were identified in 20 cases (17.9%) (Fig. 3c), most commonly in MSH3, MSH6, MLH3 or MSH4. The majority of MMR-mutant (MMRm) tumours were TP53wt (18/20 cases, 90.0%).